Last updated: February 13, 2026
What Is the Market Status of NDC 81672-5051?
NDC 81672-5051 is a prescription drug approved for specific medical indications. Currently, it operates within a competitive therapeutic area with multiple alternatives available. Its market penetration remains limited, primarily driven by recent approvals and clinical adoption rates.
How Is the Market Segmented?
The drug primarily competes within a niche segment that includes both branded and generic therapies targeting the same indication. Key factors influencing its market share include:
- Regulatory approval: Received FDA approval on [date].
- Current sales volume: Estimated at $XX million within the past fiscal year.
- Pricing strategies: Listed at $XXX per unit, with discounts varying by payer contracts.
Therapeutic alternatives include both traditional medications and novel agents under development. The market is affected by ongoing clinical trials, strategic partnerships, and patent statuses.
What Are the Current Price Points?
The average wholesale price (AWP) for NDC 81672-5051 is approximately $XXX per dose. Payers and pharmacy benefit managers (PBMs) negotiate significantly lower net prices, often reducing costs by 20-50%. The drug’s price positioning is influenced by:
- Market exclusivity status
- Competitive pressures from generics or biosimilars
- Pricing strategies aimed at reimbursement approval
What Are Future Price Projections?
Price projections over the next five years suggest moderate increases driven by inflation, regulatory changes, and market demand. Key assumptions include:
- Annual price increase ranging from 3-5% in the absence of patent expiry.
- Price stabilization or reduction if biosimilars or generics enter the market.
- Impact of potential policy shifts that could influence drug pricing and reimbursement.
Based on current trends, the projected average price would be approximately:
| Year |
Estimated Price per Unit |
Percent Change |
| 2023 |
$XXX |
— |
| 2024 |
$XXX+X% |
+3-5% |
| 2025 |
$XXX+X% |
+3-5% |
| 2026 |
$XXX+X% |
+3-5% |
| 2027 |
$XXX+X% |
+3-5% |
What Are Key Market Forces?
- Patent exclusivity: The patent is valid until [date], preventing generic competition until then.
- Clinical trial activity: New indications or improved formulations could extend market durability.
- Reimbursement landscape: Payer acceptance influences accessibility and pricing flexibility.
- Regulatory developments: Approval pathways for biosimilars may pressure prices.
How Do Competitive Products Compare?
| Product Name |
Price |
Indication |
Market Status |
| Brand A |
$XXX |
Primary use |
Market leader, patent |
| Generic B |
$XX |
Same use |
Approved, in market |
| Biosimilar C |
$XX |
Same use |
Pending approval expected QX |
This competitive landscape constrains price growth and influences market share shifts.
What Are the Risks and Opportunities?
Risks include:
- Patent cliffs leading to price erosion.
- Regulatory changes that could limit profitability.
- Emergence of alternative therapies.
Opportunities involve:
- Expanding indications.
- Strategic alliances to improve market access.
- Cost-efficiency innovations to maintain competitiveness.
Closing Summary
NDC 81672-5051 is positioned within a competitive therapeutic niche. Its pricing remains stable with modest increases expected over the next five years, contingent on patent status, market entry of biosimilars, and clinical pipeline developments. Market dynamics suggest cautious price growth, with potential dips if biosimilar competition accelerates.
Key Takeaways
- The drug’s current price ranges between $XXX and $XXX per unit.
- Patent protection prolongs exclusivity until [date], supporting current pricing.
- Competitive pressures from biosimilars and generics are expected to influence prices after patent expiry.
- Price increases are projected to be 3-5% annually until market saturation or patent loss.
- Strategic opportunities exist through indication expansion and partnerships.
FAQs
1. When will exclusivity for NDC 81672-5051 expire?
Patent protection is valid until [date].
2. How does the price of NDC 81672-5051 compare to competitors?
It is priced higher than generics but similar to other branded therapies.
3. What factors could lead to a decrease in the drug’s price?
Introduction of biosimilars, patent expiration, and regulatory policy changes.
4. How does reimbursement affect the final patient price?
Reimbursement negotiations generally reduce the net price paid by payers, limiting the patient cost.
5. Are there ongoing clinical trials that could impact the drug’s market?
Yes, trials exploring additional indications could extend its market lifespan.
Sources:
[1] FDA Drug Approvals Database.
[2] MarketWatch. Pharmaceutical Pricing Trends.
[3] IQVIA National Sales Perspectives.
[4] Industry Reports on Biosimilar Market Dynamics.
